Literature DB >> 883058

Nephrectomy for renal cell carcinoma with metastases.

S Z Freed.   

Abstract

The percentage of patients with renal cell carcinoma who also have identifiable metastases when first seen is increasing. In the past metastases were considered justification for excluding nephrectomy in the management of the patient. However, numerous opportunities for therapy which are abetted by removal of the primary tumor are presented. It is concluded, depending on several variables, that the advantages of nephrectomy usually justify the procedure.

Entities:  

Mesh：

Year:  1977        PMID： 883058     DOI： 10.1016/0090-4295(77)90303-x

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


  8 in total

Review 1.  The role of resection for patients with renal carcinoma.

Authors:  R C Flanigan; P M Yonover
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

Review 2.  Local treatment of metastatic cancer--killing the seed or disturbing the soil?

Authors:  Scott C Morgan; Chris C Parker
Journal:  Nat Rev Clin Oncol       Date:  2011-06-07       Impact factor: 66.675

Review 3.  Novel therapies in small cell lung cancer.

Authors:  Hirva Mamdani; Raghava Induru; Shadia I Jalal
Journal:  Transl Lung Cancer Res       Date:  2015-10

4.  Artificial graft patch reconstruction of infiltrated inferior vena cava in renal adenocarcinoma.

Authors:  D Kontothanassis; F Sofras; D Kouroupakis; N Setakis
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 5.  Cytoreductive nephrectomy in metastatic renal cancer.

Authors:  Robert C Flanigan
Journal:  Curr Urol Rep       Date:  2003-02       Impact factor: 2.862

6.  Repeated pancreatectomy for metachronous duodenal and pancreatic metastases of renal cell carcinoma.

Authors:  Tatsuo Hata; Naoaki Sakata; Takeshi Aoki; Hiroshi Yoshida; Atsushi Kanno; Fumiyoshi Fujishima; Fuyuhiko Motoi; Atsushi Masamune; Tooru Shimosegawa; Michiaki Unno
Journal:  Case Rep Gastroenterol       Date:  2013-10-09

7.  A rationale for surgical debulking to improve anti-PD1 therapy outcome in non small cell lung cancer.

Authors:  Florian Guisier; Stephanie Cousse; Mathilde Jeanvoine; Luc Thiberville; Mathieu Salaun
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

Review 8.  Metastatic renal cell carcinoma.

Authors:  Robert C Flanigan; Steven C Campbell; Joseph I Clark; Maria M Picken
Journal:  Curr Treat Options Oncol       Date:  2003-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.